- October 12th 2012
Physicians have more research to help them reassure patients and families of the safety of the quadrivalent human papillomavirus vaccine. A study published online Oct. 1 in Archives of Pediatrics and Adolescent Medicine found no significant adverse events associated with the vaccine.
The findings should help alleviate concerns about the HPV vaccine, said Nicola Klein, MD, PhD, lead study author and research scientist and co-director of the Kaiser Permanente Vaccine Study Center in Oakland, Calif. The vaccine has faced controversy since it received Food and Drug Administration approval in 2006. Its vaccination rates have been lower than other vaccines, Dr. Klein said.
Thirty-five percent of girls 11 to 17 received all three recommended doses of the HPV vaccine in 2011, according to the Centers for Disease Control and Prevention’s latest data.
For the Archives study, researchers followed 189,629 girls and women 9 to 26 who received a total of 346,972 doses of the vaccine betwe [Read more]